A retrospective observational study of investigating the real world data of post-treatment after drug-induced lung injury by osimertinib and the safety and efficacy of EGFR-TKI re-challenge
Not Applicable
Recruiting
- Conditions
- on small cell lung cancer
- Registration Number
- JPRN-UMIN000044854
- Lead Sponsor
- Thoracic Oncology Research Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
Patients participating in studies aimed at similar analysis of treatment after Osimertinib
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method